Clinical trial
A Randomized Study Evaluating the Feasibility and Activity of Three Different Combination With Gemcitabine as First Line Therapy for Non Small Cell Lung Cancer
NCT00191490
Study timeline
Study start (unknown)2002-07-01Date precision: month
Registry last updated2007-01-26
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Carcinoma, Non-Small-Cell Lungunresolved
Interventions
GemcitabineDRUG · verified · RxNorm: gemcitabine
docetaxelDRUG · verified · RxNorm: docetaxel
cisplatinDRUG · verified · RxNorm: cisplatin
Sponsors & collaborators
Eli Lilly and Companylead sponsor
Aventis Pharmaceuticalscollaborator
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00191490 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.